Ligand validation:3N62

XFJ: 6,6'-(pyridine-3,5-diyldiethane-2,1-diyl)bis(4-methylpyridin-2-amine)

XFJ is a Ligand Of Interest in 3N62 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3N62_XFJ_B_800	52%	32%	0.181	0.941	0.78	2	1	11	1	0	100%	1
3N62_XFJ_A_800	31%	33%	0.23	0.901	0.72	2.02	-	12	2	0	100%	1
3N62_XFJ_B_805	25%	43%	0.295	0.93	0.35	1.87	-	13	5	0	100%	0.5
3N62_XFJ_B_719	24%	42%	0.283	0.915	0.35	1.91	-	13	4	0	100%	0.5
3N65_XFJ_B_800	78%	26%	0.11	0.953	0.88	2.24	1	15	1	0	100%	1
3N5W_XFJ_B_800	66%	33%	0.158	0.964	0.77	1.99	-	11	1	0	100%	1
3N61_XFJ_B_800	45%	31%	0.181	0.913	0.69	2.16	-	15	3	0	100%	1
3N6F_XFJ_A_800	44%	35%	0.226	0.956	0.65	1.96	-	9	1	0	100%	1
3N5T_XFJ_A_800	42%	31%	0.208	0.928	0.65	2.19	-	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.